Institute of Biomedical Research Corp MRES

Institute of Biomedical Research Corp OTC
No trades
Upcoming Earnings
Market Cap
Div Yield
Upcoming Earnings
Market Cap
Div Yield
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM


Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Institute of BioMedical Research Corp. engages in research and development, quality control and standardization of pharmaceuticals, cosmetics and food products. Its products include Aerosan, MicrobEX, Klenet microbicidal towels, OralNet and Oral Ocean Power mouthwash, Purilair, colloidal silver, electro medical devices, beauty devices, electrodes, and garment electrodes. It also offers quality control, regulatory, and health care services; environmental analyses; building decontamination; and environmental protection and management services. The company was founded on July 26, 1990 and is headquartered in Niksic, Montenegro.